Bile acids in drug induced liver injury: Key players and surrogate markers

Clin Res Hepatol Gastroenterol. 2016 Jun;40(3):257-266. doi: 10.1016/j.clinre.2015.12.017. Epub 2016 Feb 10.

Abstract

Bile acid research has gained great momentum since the role of bile acids as key signaling molecules in the enterohepatic circulation was discovered. Their physiological function in regulating their own homeostasis, as well as energy and lipid metabolism make them interesting targets for the pharmaceutical industry in the context of diseases such as bile acid induced diarrhea, bile acid induced cholestasis or nonalcoholic steatohepatitis. Changes in bile acid homeostasis are also linked to various types of drug-induced liver injury (DILI). However, the key question whether bile acids are surrogate markers for monitoring DILI or key pathogenic players in the onset and progression of DILI is under intense investigation. The purpose of this review is to summarize the different facets of bile acids in the context of normal physiology, hereditary defects of bile acid transport and DILI.

Publication types

  • Review

MeSH terms

  • Bile Acids and Salts / metabolism*
  • Bile Ducts / cytology
  • Biological Transport / physiology
  • Biomarkers / metabolism
  • Chemical and Drug Induced Liver Injury / metabolism*
  • Cholestasis, Intrahepatic / chemically induced
  • Cholestasis, Intrahepatic / physiopathology
  • Enterohepatic Circulation / physiology
  • Homeostasis
  • Humans

Substances

  • Bile Acids and Salts
  • Biomarkers